Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: BlueRock Therapeutics LP
March 23, 2026
BlueRock Therapeutics LP
Orphan Drug Designation
treatment of cone-rod dystrophy
Disease Area:
Rare Disease
Source
December 10, 2025
BlueRock Therapeutics LP
Orphan Drug Designation
FDA orphan drug designation: treatment of retinitis pigmentosa
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
